Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for lactose intolerance has been reported in the published literature.
7 clinical trials registered, 2 recruiting. Interventions under study include other interventions and drug therapy. Pipeline includes 4 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06773650](https://clinicaltrials.gov/study/NCT06773650) |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 12:11 PM UTC
Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance
— |
European Institute of Oncology |
RECRUITING |
[NCT06931379](https://clinicaltrials.gov/study/NCT06931379) | Screening of Lactose Intolerance Among IBS Patients Diarrhea Dominant | — | Assiut University | NOT_YET_RECRUITING |
[NCT06177938](https://clinicaltrials.gov/study/NCT06177938) | Lactobreath: A Study to Diagnose Lactose Intolerance Using Breath Markers | NA | ETH Zurich | RECRUITING |
[NCT06513026](https://clinicaltrials.gov/study/NCT06513026) | Milk for Diabetes Prevention | NA | Albert Einstein College of Medicine | UNKNOWN |
[NCT07424898](https://clinicaltrials.gov/study/NCT07424898) | Lactose Intolerance and Intestinal Permability | — | Bezmialem Vakif University | UNKNOWN |
217 publications have been identified in PubMed for lactose intolerance. Kisho has analyzed 116 by research type. Research spans Review / Meta-Analysis (35%), Basic Science / Preclinical (17%), and Clinical Trial Publication (12%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 41 | 35% |
Laboratory research | 20 | 17% |
Clinical study results | 14 | 12% |
Disease patterns and progression | 14 | 12% |
Testing and diagnosis research | 13 | 11% |
Patient case studies | 7 | 6% |
New treatment approaches | 5 | 4% |
Other research | 2 | 2% |
Perets TT (2026). [PMID: 41843249](https://pubmed.ncbi.nlm.nih.gov/41843249/). *Antonie Van Leeuwenhoek*. [Review / Meta-Analysis]
Cassella DG (2026). [PMID: 41308874](https://pubmed.ncbi.nlm.nih.gov/41308874/). *Clin Nutr ESPEN*. [Diagnostic / Biomarker]
Mikhael-Moussa H (2026). [PMID: 40197400](https://pubmed.ncbi.nlm.nih.gov/40197400/). *Am J Gastroenterol*. [Gene Therapy / Novel Therapeutics]
DE Morais GP (2026). [PMID: 41482367](https://pubmed.ncbi.nlm.nih.gov/41482367/). *In Vivo*. [Diagnostic / Biomarker]
Awosika A (2026). [PMID: 41640614](https://pubmed.ncbi.nlm.nih.gov/41640614/). *World J Gastroenterol*. [Review / Meta-Analysis]
Mavromati M (2026). [PMID: 41643853](https://pubmed.ncbi.nlm.nih.gov/41643853/). *Ann Endocrinol (Paris)*. [Review / Meta-Analysis]
Ma B (2026). [PMID: 41348203](https://pubmed.ncbi.nlm.nih.gov/41348203/). *Naunyn Schmiedebergs Arch Pharmacol*. [Basic Science / Preclinical]
Casciano F (2026). [PMID: 41794463](https://pubmed.ncbi.nlm.nih.gov/41794463/). *Food Res Int*. [Gene Therapy / Novel Therapeutics]
Hao Y (2026). [PMID: 41754171](https://pubmed.ncbi.nlm.nih.gov/41754171/). *Nutrients*. [Basic Science / Preclinical]
Kuang J (2026). [PMID: 42093997](https://pubmed.ncbi.nlm.nih.gov/42093997/). *Front Immunol*. [Diagnostic / Biomarker]